ConductScience.org, home

Paper39083151

Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial.

Cooper SE and 10 others. AIDS Behav, 2024. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial. Papers, record 39083151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39083151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial.
PubMed
Journal
AIDS Behav
PubMed
Year
2024
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Clinical Trial, Phase II
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.45, provisional
iCite
Revised in PubMed
2026-09-25
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cooper SEStanley Ehttps://orcid.org/0000-0003-3371-0845
2Zhang SShuaiqi
3Haines DDaniel
4Mayer KHKenneth H
5Amico KRK Rivet
6Landovitz RJRaphael J
7Hendrix CWCraig W
8Marzinke MAMark A
9Chege WWairimu
10McCauley MMarybeth
11Gulick RMRoy M

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Self ReportMajor topic
HIV InfectionsMajor topic
Anti-HIV AgentsMajor topic
TenofovirMajor topic
EmtricitabineMajor topic
MaravirocMajor topic
Pre-Exposure ProphylaxisMajor topic
Drug MonitoringMajor topic
Humans
Male
Female
Adult
Double-Blind Method
Middle Aged
Cyclohexanes

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
UM1 AI069424NIAID NIH HHSUnited StatesUM1AI069424PubMedNIH RePORTER
T32 AI007613NIAID NIH HHSUnited StatesT32AI007613PubMed and NIHNIH RePORTER
T32AI007613Division of Intramural Research, National Institute of Allergy and Infectious DiseasesT32AI007613PubMed and NIHNIH RePORTER
UM1 AI068619NIAID NIH HHSUnited StatesUM1AI068619PubMed and NIHNIH RePORTER
UM1 AI068613NIAID NIH HHSUnited StatesUM1AI068613PubMed and NIHNIH RePORTER
UM1 AI069419NIAID NIH HHSUnited StatesUM1AI069419PubMedNIH RePORTER
UM1 AI068636NIAID NIH HHSUnited StatesUM1AI068636PubMed and NIHNIH RePORTER
UM1 AI068617NIAID NIH HHSUnited StatesUM1AI068617PubMed and NIHNIH RePORTER

Download CSV of grants

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125296098Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures.J Acquir Immune Defic Syndr2015https://conductscience.org/library/papers/25296098PubMed
226334052No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.Clin Infect Dis2015https://conductscience.org/library/papers/26334052PubMed
333831911Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis.AIDS2021https://conductscience.org/library/papers/33831911PubMed
427333000Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting.PLoS One2016https://conductscience.org/library/papers/27333000PubMed
524926036Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence.Clin Infect Dis2014https://conductscience.org/library/papers/24926036PubMed
629090394Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value.AIDS Behav2018https://conductscience.org/library/papers/29090394PubMed
734143779PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.PLoS Med2021https://conductscience.org/library/papers/34143779PubMed
826364263Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.Lancet2016https://conductscience.org/library/papers/26364263PubMed
928902074Plasma Tenofovir Levels to Support Adherence to TDF/FTC Preexposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California.J Acquir Immune Defic Syndr2017https://conductscience.org/library/papers/28902074PubMed
1031430318Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study.PLoS One2019https://conductscience.org/library/papers/31430318PubMed
1125651245Tenofovir-based preexposure prophylaxis for HIV infection among African women.N Engl J Med2015https://conductscience.org/library/papers/25651245PubMed
1222784040Preexposure prophylaxis for HIV infection among African women.N Engl J Med2012https://conductscience.org/library/papers/22784040PubMed
1321091279Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.N Engl J Med2010https://conductscience.org/library/papers/21091279PubMed
1426414912Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066).AIDS Res Hum Retroviruses2016https://conductscience.org/library/papers/26414912PubMed
1526850270Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study.J Int AIDS Soc2016https://conductscience.org/library/papers/26850270PubMed
1631298662Changes in HIV Preexposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men - 20 Urban Areas, 2014 and 2017.MMWR Morb Mortal Wkly Rep2019https://conductscience.org/library/papers/31298662PubMed
1735687192
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305).
AIDS Behav2022https://conductscience.org/library/papers/35687192PubMed
1817577653Optimal recall period and response task for self-reported HIV medication adherence.AIDS Behav2008https://conductscience.org/library/papers/17577653PubMed
1927811319Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).J Infect Dis2017https://conductscience.org/library/papers/27811319PubMed
2024077970Cognitive and field testing of a new set of medication adherence self-report items for HIV care.AIDS Behav2014https://conductscience.org/library/papers/24077970PubMed

See all 41 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42802252Associations Between Psychosocial Factors and Pre-exposure Prophylaxis (PrEP) Adherence Among Black Men Who Have Sex with Men in Ending the HIV Epidemic Jurisdictions: Findings from Project Adhere.Arch Sex Behav2026https://conductscience.org/library/papers/42802252PubMed
42484761The Effects of Alcohol Intoxication on Sexual Risk Behavior in Men Who Have Sex with Men: Considering PrEP, HIV Viral Load, and Inhibition Conflict.AIDS Behav2026https://conductscience.org/library/papers/42484761PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39083151

GET https://conductscience.org/api/papers/v1/39083151/references?page=2